Public Profile

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a leading biopharmaceutical company based in China, focuses on innovative drug discovery and development. Founded in 2015, the company has rapidly established itself in the biotechnology sector, with its headquarters in Beijing and operational reach across major regions in China. Specialising in monoclonal antibodies and gene editing technologies, Biocytogen is renowned for its unique animal models that facilitate advanced preclinical research. The company’s commitment to innovation has positioned it as a key player in the global biopharmaceutical landscape, with notable achievements in therapeutic development and collaborations with various research institutions. With a strong emphasis on quality and scientific excellence, Biocytogen continues to drive advancements in the industry, contributing significantly to the future of healthcare solutions.

DitchCarbon Score

How does Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s score of 29 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Let us know if this data was useful to you

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s reported carbon emissions

In 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported total carbon emissions of approximately 23,506,310 kg CO2e for Scope 1 and 240 kg CO2e for Scope 2. The company also recorded significant emissions from Scope 3, amounting to about 57,347,000 kg CO2e, primarily from purchased goods and services. In 2022, the emissions were notably higher, with Scope 1 and Scope 2 emissions each at approximately 19,472,490 kg CO2e, while Scope 3 emissions were not reported. Despite these figures, Biocytogen has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate pledges or science-based targets indicates a potential area for improvement in their sustainability strategy. The company’s emissions intensity metrics, such as 240 kg CO2e per square metre and 0.00058 kg CO2e per RMB 1,000 expenditure, suggest a focus on operational efficiency, yet further commitments to emissions reduction would enhance their climate responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
19,472,490
00,000,000
Scope 2
19,472,490
000
Scope 3
-
000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adimab

US
Chemicals nec
Updated 2 days ago

AbCellera

CA
Education services (80)
Updated 2 days ago

Regeneron

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Ablexis, LLC

US
Health and social work services (85)
Updated 2 days ago

OmniAb, Inc.

US
Health and social work services (85)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers